<!doctype html><html lang=en><head><meta charset=utf-8><meta name=description content="[!warning] IBD ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà IBS IBS ‡πÄ‡∏õ‡πá‡∏ô functional ‡∏ï‡πà‡∏≤‡∏á‡∏ó‡∏µ‡πà IBD ‡∏ó‡∏µ‡πà‡∏û‡∏¢‡∏≤‡∏ò‡∏¥‡∏™‡∏†‡∏≤‡∏û‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô
  Crohn&rsquo;s Disease vs Ulcerative Colitis  UC ‡∏à‡∏≥‡∏ß‡πà‡∏≤ &ldquo;‡πÄ‡∏≠‡∏≤‡∏™‡∏¥&rdquo; = S&S ‡πÄ‡∏î‡πà‡∏ô‡∏ï‡∏£‡∏á rectum ‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏¢ ‡πÜ ‡πÅ‡∏ï‡πà‡πÑ‡∏°‡πà‡∏•‡∏∂‡∏Å‡∏°‡∏≤‡∏Å ‡∏ï‡πà‡∏≤‡∏á‡∏à‡∏≤‡∏Å CD ‡∏ó‡∏µ‡πà‡∏Å‡∏£‡∏∞‡∏à‡∏±‡∏î‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ CD ‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô systemic symptoms ‡∏à‡∏∂‡∏á‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏°‡∏≤‡∏Å ‡πÜ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á abdominal ‡∏ó‡∏µ‡πà‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏≠‡∏µ‡∏Å ‡πÄ‡∏ä‡πà‡∏ô tenderness, pain ‡∏Ø‡∏•‡∏Ø ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á‡πÑ‡∏Ç‡πâ‡∏≠‡∏µ‡∏Å‡∏î‡πâ‡∏ß‡∏¢ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ aphthous or linear ulcers ‡∏≠‡∏µ‡∏Å UC ‡∏à‡∏∞‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô (and common) ‡∏ß‡πà‡∏≤‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà rectum ‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡πÅ‡∏ö‡∏ö continuous   Epidemiology  ‡∏û‡∏ö‡πÄ‡∏¢‡∏≠‡πÉ‡∏ô‡∏ï‡∏∞‡∏ß‡∏±‡∏ô‡∏ï‡∏Å UC ‡∏û‡∏ö‡πÑ‡∏î‡πâ‡∏ö‡πà‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤ CD ‡πÅ‡∏ï‡πà‡∏ï‡πà‡∏≤‡∏á‡∏Å‡∏±‡∏ô‡∏ô‡∏¥‡∏î‡πÄ‡∏î‡∏µ‡∏¢‡∏ß   Pathophysiology (‡∏´‡∏•‡∏≤‡∏Å‡∏´‡∏•‡∏≤‡∏¢, in short;)  microbiome ‡πÄ‡∏™‡∏µ‡∏¢‡∏™‡∏°‡∏î‡∏∏‡∏• ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∞‡∏ó‡∏≤‡∏ô‡∏≠‡∏≤‡∏´‡∏≤‡∏£ FODMAPs Psychological Stress TNF-a ‡∏ó‡∏µ‡πà‡∏™‡∏π‡∏á ‡∏ó‡∏≥‡πÉ‡∏´‡πâ th1 th2 dysfunction   Severity  Mild  ‡∏ñ‡πà‡∏≤‡∏¢‡∏ô‡πâ‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ESR ‡∏õ‡∏Å‡∏ï‡∏¥ (< 30 mm/h)   Moderate  ‡∏ñ‡πà‡∏≤‡∏¢‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á systemic ‡πÄ‡∏•‡πá‡∏Å‡∏ô‡πâ‡∏≠‡∏¢   Severe  ‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 6 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ‡∏°‡∏µ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏¥‡∏á‡∏£‡∏∞‡∏ö‡∏ö   Fulminant  ‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 10 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ‡∏Å‡∏î‡πÄ‡∏à‡πá‡∏ö S&S of toxic megacolon     Extraintestinal manifestations ‡πÄ‡∏î‡πà‡∏ô‡πÉ‡∏ô CD ‡πÄ‡∏ä‡πà‡∏ô Uveitis, Scleritis, Episcleritis ‡∏õ‡∏ß‡∏î‡∏Ç‡πâ‡∏≠ ‡∏õ‡∏ß‡∏î‡πÄ‡∏Ç‡πà‡∏≤‡∏Å‡πá‡∏û‡∏ö‡πÑ‡∏î‡πâ‡πÄ‡∏ä‡πà‡∏ô‡∏Å‡∏±‡∏ô Goal of Therapy:  ‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏∏‡∏ô‡πÅ‡∏£‡∏á ‡∏õ‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏Å‡∏¥‡∏î‡∏†‡∏≤‡∏ß‡∏∞‡∏∞‡πÅ‡∏ó‡∏£‡∏Å‡∏ã‡πâ‡∏≠‡∏ô ‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ñ‡∏µ‡πà‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏Å‡∏≥‡πÄ‡∏£‡∏¥‡∏ö   ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤‡πÇ‡∏î‡∏¢‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏¢‡∏≤  Salicylate derivatives ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á induction and maintenance  ‡∏ï‡∏±‡∏ß active ‡∏Ñ‡∏∑‡∏≠ 5-aminosalicylic acid (mesalamine) ‡∏°‡∏µ‡∏ú‡∏•‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏Ñ‡∏µ‡∏¢‡∏á‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡πÑ‡∏î‡πâ‡πÅ‡∏Å‡πà ‡∏Ñ‡∏•‡∏∑‡πà‡∏ô‡πÑ‡∏™‡πâ ‡∏≠‡∏≤‡πÄ‡∏à‡∏µ‡∏¢‡∏ô ‡∏õ‡∏ß‡∏î‡∏®‡∏£‡∏µ‡∏©‡∏∞ ‡πÄ‡∏ö‡∏∑‡πà‡∏≠‡∏≠‡∏≤‡∏´‡∏≤‡∏£ Sulfasalazine (sulfapyridine + 5-ASA)  ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡∏ú‡∏°‡∏£‡πà‡∏ß‡∏á ‡∏ú‡∏∑‡πà‡∏ô‡πÅ‡∏û‡πâ ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á ‡∏™‡∏≤‡∏£‡∏Ñ‡∏±‡∏î‡∏´‡∏•‡∏±‡πà‡∏á‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡∏™‡∏µ‡∏™‡πâ‡∏° (‡∏ô‡πâ‡∏≥‡∏ï‡∏≤ ‡πÄ‡∏´‡∏á‡∏∑‡πà‡∏≠ ‡∏õ‡∏±‡∏™‡∏™‡∏≤‡∏ß‡∏∞) ‡∏£‡∏∞‡∏ß‡∏±‡∏á anemia thrombocytopenia ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡πÉ‡∏ô‡∏Ñ‡∏ô‡πÅ‡∏û‡πâ sulfa sulfapyridine ‡πÄ‡∏õ‡πá‡∏ô antibiotics ‡πÅ‡∏ï‡πà‡πÄ‡∏£‡∏≤‡∏ô‡∏≥‡∏°‡∏≤‡∏ú‡∏™‡∏°‡πÄ‡∏û‡∏∑‡πà‡∏≠‡πÉ‡∏ä‡πâ‡πÄ‡∏õ‡πá‡∏ô carriers ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ ‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏ï‡∏±‡∏ß 5-ASA ‡∏î‡∏π‡∏î‡∏ã‡∏∂‡∏°‡πÑ‡∏î‡πâ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ô‡πâ‡∏≠‡∏¢   ‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡πÄ‡∏£‡∏≤‡∏°‡∏µ mesalamine ‡πÄ‡∏î‡∏µ‡πà‡∏¢‡∏ß ‡∏ó‡∏±‡πâ‡∏á‡πÉ‡∏ô‡∏£‡∏π‡∏õ‡∏Ç‡∏≠‡∏á suppository, enema, oral   Corticosteroids ‡∏°‡∏±‡∏Å‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö‡∏¢‡∏≤‡∏ï‡∏±‡∏ß‡∏≠‡∏∑‡πà‡∏ô‡∏î‡πâ‡∏ß‡∏¢‡πÄ‡∏™‡∏°‡∏≠  Prednisolone ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡πÅ‡∏Ñ‡πà‡πÉ‡∏ô severe ‡∏õ‡∏Å‡∏ï‡∏¥‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 40-60 mg/d ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 2-3 ‡∏ß‡∏µ‡∏Ñ Budesonide ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á mild-mod-severe   Thiopurine (Azathioprine; pro-drug)  ‡∏ï‡πâ‡∏≠‡∏á‡∏ó‡∏î‡∏™‡∏≠‡∏ö TPMT   Anti-TNF  ‡∏´‡πâ‡∏≤‡∏°‡πÉ‡∏ä‡πâ‡πÉ‡∏ô toxic megacolon ‡πÅ‡∏•‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏ä‡πá‡∏Ñ lab TPS, hepatitis   Anti-integrin, IL-12, IL-23 inhibitor, JAK inhibitor, Calcineurin inhibitor ‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡πÄ‡∏Ñ‡∏™‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡∏ï‡∏≠‡∏ö‡∏™‡∏ô‡∏≠‡∏á‡∏ï‡πà‡∏≠ steroid ‡πÅ‡∏•‡∏∞‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡πÅ‡∏Ñ‡πà induction ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ S/E ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏¢‡∏≠‡∏∞‡∏°‡∏≤‡∏Å ‡πÜ   ‡πÅ‡∏ô‡∏ß‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤  ‡∏à‡∏∏‡∏î‡∏™‡∏±‡∏á‡πÄ‡∏Å‡∏ï: ‡πÉ‡∏ô fulminant ‡∏à‡∏∞‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏û‡∏ß‡∏Å methyprednisolone / hydrocortisone ‡∏Å‡πà‡∏≠‡∏ô ‡∏ñ‡πâ‡∏≤‡∏´‡∏≤‡∏¢‡∏Ñ‡πà‡∏≠‡∏¢‡∏•‡∏î‡πÄ‡∏õ‡πá‡∏ô prednisolone ‡πÉ‡∏ô Cohn Disease ‡∏ñ‡πâ‡∏≤ Severe or Mod ‡∏≠‡∏≤‡∏à‡πÉ‡∏ä‡πâ Prednisolone ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö TNF-a inhibitor ‡∏´‡∏£‡∏∑‡∏≠ immunosupressive ‡πÑ‡∏õ‡πÄ‡∏•‡∏¢ !"><meta property="og:title" content><meta property="og:description" content="[!warning] IBD ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà IBS IBS ‡πÄ‡∏õ‡πá‡∏ô functional ‡∏ï‡πà‡∏≤‡∏á‡∏ó‡∏µ‡πà IBD ‡∏ó‡∏µ‡πà‡∏û‡∏¢‡∏≤‡∏ò‡∏¥‡∏™‡∏†‡∏≤‡∏û‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô
  Crohn&rsquo;s Disease vs Ulcerative Colitis  UC ‡∏à‡∏≥‡∏ß‡πà‡∏≤ &ldquo;‡πÄ‡∏≠‡∏≤‡∏™‡∏¥&rdquo; = S&S ‡πÄ‡∏î‡πà‡∏ô‡∏ï‡∏£‡∏á rectum ‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏¢ ‡πÜ ‡πÅ‡∏ï‡πà‡πÑ‡∏°‡πà‡∏•‡∏∂‡∏Å‡∏°‡∏≤‡∏Å ‡∏ï‡πà‡∏≤‡∏á‡∏à‡∏≤‡∏Å CD ‡∏ó‡∏µ‡πà‡∏Å‡∏£‡∏∞‡∏à‡∏±‡∏î‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ CD ‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô systemic symptoms ‡∏à‡∏∂‡∏á‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏°‡∏≤‡∏Å ‡πÜ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á abdominal ‡∏ó‡∏µ‡πà‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏≠‡∏µ‡∏Å ‡πÄ‡∏ä‡πà‡∏ô tenderness, pain ‡∏Ø‡∏•‡∏Ø ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á‡πÑ‡∏Ç‡πâ‡∏≠‡∏µ‡∏Å‡∏î‡πâ‡∏ß‡∏¢ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ aphthous or linear ulcers ‡∏≠‡∏µ‡∏Å UC ‡∏à‡∏∞‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô (and common) ‡∏ß‡πà‡∏≤‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà rectum ‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡πÅ‡∏ö‡∏ö continuous   Epidemiology  ‡∏û‡∏ö‡πÄ‡∏¢‡∏≠‡πÉ‡∏ô‡∏ï‡∏∞‡∏ß‡∏±‡∏ô‡∏ï‡∏Å UC ‡∏û‡∏ö‡πÑ‡∏î‡πâ‡∏ö‡πà‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤ CD ‡πÅ‡∏ï‡πà‡∏ï‡πà‡∏≤‡∏á‡∏Å‡∏±‡∏ô‡∏ô‡∏¥‡∏î‡πÄ‡∏î‡∏µ‡∏¢‡∏ß   Pathophysiology (‡∏´‡∏•‡∏≤‡∏Å‡∏´‡∏•‡∏≤‡∏¢, in short;)  microbiome ‡πÄ‡∏™‡∏µ‡∏¢‡∏™‡∏°‡∏î‡∏∏‡∏• ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∞‡∏ó‡∏≤‡∏ô‡∏≠‡∏≤‡∏´‡∏≤‡∏£ FODMAPs Psychological Stress TNF-a ‡∏ó‡∏µ‡πà‡∏™‡∏π‡∏á ‡∏ó‡∏≥‡πÉ‡∏´‡πâ th1 th2 dysfunction   Severity  Mild  ‡∏ñ‡πà‡∏≤‡∏¢‡∏ô‡πâ‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ESR ‡∏õ‡∏Å‡∏ï‡∏¥ (< 30 mm/h)   Moderate  ‡∏ñ‡πà‡∏≤‡∏¢‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á systemic ‡πÄ‡∏•‡πá‡∏Å‡∏ô‡πâ‡∏≠‡∏¢   Severe  ‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 6 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ‡∏°‡∏µ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏¥‡∏á‡∏£‡∏∞‡∏ö‡∏ö   Fulminant  ‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 10 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ‡∏Å‡∏î‡πÄ‡∏à‡πá‡∏ö S&S of toxic megacolon     Extraintestinal manifestations ‡πÄ‡∏î‡πà‡∏ô‡πÉ‡∏ô CD ‡πÄ‡∏ä‡πà‡∏ô Uveitis, Scleritis, Episcleritis ‡∏õ‡∏ß‡∏î‡∏Ç‡πâ‡∏≠ ‡∏õ‡∏ß‡∏î‡πÄ‡∏Ç‡πà‡∏≤‡∏Å‡πá‡∏û‡∏ö‡πÑ‡∏î‡πâ‡πÄ‡∏ä‡πà‡∏ô‡∏Å‡∏±‡∏ô Goal of Therapy:  ‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏∏‡∏ô‡πÅ‡∏£‡∏á ‡∏õ‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏Å‡∏¥‡∏î‡∏†‡∏≤‡∏ß‡∏∞‡∏∞‡πÅ‡∏ó‡∏£‡∏Å‡∏ã‡πâ‡∏≠‡∏ô ‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ñ‡∏µ‡πà‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏Å‡∏≥‡πÄ‡∏£‡∏¥‡∏ö   ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤‡πÇ‡∏î‡∏¢‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏¢‡∏≤  Salicylate derivatives ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á induction and maintenance  ‡∏ï‡∏±‡∏ß active ‡∏Ñ‡∏∑‡∏≠ 5-aminosalicylic acid (mesalamine) ‡∏°‡∏µ‡∏ú‡∏•‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏Ñ‡∏µ‡∏¢‡∏á‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡πÑ‡∏î‡πâ‡πÅ‡∏Å‡πà ‡∏Ñ‡∏•‡∏∑‡πà‡∏ô‡πÑ‡∏™‡πâ ‡∏≠‡∏≤‡πÄ‡∏à‡∏µ‡∏¢‡∏ô ‡∏õ‡∏ß‡∏î‡∏®‡∏£‡∏µ‡∏©‡∏∞ ‡πÄ‡∏ö‡∏∑‡πà‡∏≠‡∏≠‡∏≤‡∏´‡∏≤‡∏£ Sulfasalazine (sulfapyridine + 5-ASA)  ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡∏ú‡∏°‡∏£‡πà‡∏ß‡∏á ‡∏ú‡∏∑‡πà‡∏ô‡πÅ‡∏û‡πâ ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á ‡∏™‡∏≤‡∏£‡∏Ñ‡∏±‡∏î‡∏´‡∏•‡∏±‡πà‡∏á‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡∏™‡∏µ‡∏™‡πâ‡∏° (‡∏ô‡πâ‡∏≥‡∏ï‡∏≤ ‡πÄ‡∏´‡∏á‡∏∑‡πà‡∏≠ ‡∏õ‡∏±‡∏™‡∏™‡∏≤‡∏ß‡∏∞) ‡∏£‡∏∞‡∏ß‡∏±‡∏á anemia thrombocytopenia ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡πÉ‡∏ô‡∏Ñ‡∏ô‡πÅ‡∏û‡πâ sulfa sulfapyridine ‡πÄ‡∏õ‡πá‡∏ô antibiotics ‡πÅ‡∏ï‡πà‡πÄ‡∏£‡∏≤‡∏ô‡∏≥‡∏°‡∏≤‡∏ú‡∏™‡∏°‡πÄ‡∏û‡∏∑‡πà‡∏≠‡πÉ‡∏ä‡πâ‡πÄ‡∏õ‡πá‡∏ô carriers ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ ‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏ï‡∏±‡∏ß 5-ASA ‡∏î‡∏π‡∏î‡∏ã‡∏∂‡∏°‡πÑ‡∏î‡πâ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ô‡πâ‡∏≠‡∏¢   ‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡πÄ‡∏£‡∏≤‡∏°‡∏µ mesalamine ‡πÄ‡∏î‡∏µ‡πà‡∏¢‡∏ß ‡∏ó‡∏±‡πâ‡∏á‡πÉ‡∏ô‡∏£‡∏π‡∏õ‡∏Ç‡∏≠‡∏á suppository, enema, oral   Corticosteroids ‡∏°‡∏±‡∏Å‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö‡∏¢‡∏≤‡∏ï‡∏±‡∏ß‡∏≠‡∏∑‡πà‡∏ô‡∏î‡πâ‡∏ß‡∏¢‡πÄ‡∏™‡∏°‡∏≠  Prednisolone ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡πÅ‡∏Ñ‡πà‡πÉ‡∏ô severe ‡∏õ‡∏Å‡∏ï‡∏¥‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 40-60 mg/d ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 2-3 ‡∏ß‡∏µ‡∏Ñ Budesonide ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á mild-mod-severe   Thiopurine (Azathioprine; pro-drug)  ‡∏ï‡πâ‡∏≠‡∏á‡∏ó‡∏î‡∏™‡∏≠‡∏ö TPMT   Anti-TNF  ‡∏´‡πâ‡∏≤‡∏°‡πÉ‡∏ä‡πâ‡πÉ‡∏ô toxic megacolon ‡πÅ‡∏•‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏ä‡πá‡∏Ñ lab TPS, hepatitis   Anti-integrin, IL-12, IL-23 inhibitor, JAK inhibitor, Calcineurin inhibitor ‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡πÄ‡∏Ñ‡∏™‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡∏ï‡∏≠‡∏ö‡∏™‡∏ô‡∏≠‡∏á‡∏ï‡πà‡∏≠ steroid ‡πÅ‡∏•‡∏∞‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡πÅ‡∏Ñ‡πà induction ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ S/E ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏¢‡∏≠‡∏∞‡∏°‡∏≤‡∏Å ‡πÜ   ‡πÅ‡∏ô‡∏ß‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤  ‡∏à‡∏∏‡∏î‡∏™‡∏±‡∏á‡πÄ‡∏Å‡∏ï: ‡πÉ‡∏ô fulminant ‡∏à‡∏∞‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏û‡∏ß‡∏Å methyprednisolone / hydrocortisone ‡∏Å‡πà‡∏≠‡∏ô ‡∏ñ‡πâ‡∏≤‡∏´‡∏≤‡∏¢‡∏Ñ‡πà‡∏≠‡∏¢‡∏•‡∏î‡πÄ‡∏õ‡πá‡∏ô prednisolone ‡πÉ‡∏ô Cohn Disease ‡∏ñ‡πâ‡∏≤ Severe or Mod ‡∏≠‡∏≤‡∏à‡πÉ‡∏ä‡πâ Prednisolone ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö TNF-a inhibitor ‡∏´‡∏£‡∏∑‡∏≠ immunosupressive ‡πÑ‡∏õ‡πÄ‡∏•‡∏¢ !"><meta property="og:type" content="website"><meta property="og:image" content="https://akumaharit.github.io/quartz/icon.png"><meta property="og:url" content="https://akumaharit.github.io/quartz/notes/IBD/"><meta property="og:width" content="200"><meta property="og:height" content="200"><meta name=twitter:card content="summary"><meta name=twitter:title content><meta name=twitter:description content="[!warning] IBD ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà IBS IBS ‡πÄ‡∏õ‡πá‡∏ô functional ‡∏ï‡πà‡∏≤‡∏á‡∏ó‡∏µ‡πà IBD ‡∏ó‡∏µ‡πà‡∏û‡∏¢‡∏≤‡∏ò‡∏¥‡∏™‡∏†‡∏≤‡∏û‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô
  Crohn&rsquo;s Disease vs Ulcerative Colitis  UC ‡∏à‡∏≥‡∏ß‡πà‡∏≤ &ldquo;‡πÄ‡∏≠‡∏≤‡∏™‡∏¥&rdquo; = S&S ‡πÄ‡∏î‡πà‡∏ô‡∏ï‡∏£‡∏á rectum ‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏¢ ‡πÜ ‡πÅ‡∏ï‡πà‡πÑ‡∏°‡πà‡∏•‡∏∂‡∏Å‡∏°‡∏≤‡∏Å ‡∏ï‡πà‡∏≤‡∏á‡∏à‡∏≤‡∏Å CD ‡∏ó‡∏µ‡πà‡∏Å‡∏£‡∏∞‡∏à‡∏±‡∏î‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ CD ‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô systemic symptoms ‡∏à‡∏∂‡∏á‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏°‡∏≤‡∏Å ‡πÜ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á abdominal ‡∏ó‡∏µ‡πà‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏≠‡∏µ‡∏Å ‡πÄ‡∏ä‡πà‡∏ô tenderness, pain ‡∏Ø‡∏•‡∏Ø ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á‡πÑ‡∏Ç‡πâ‡∏≠‡∏µ‡∏Å‡∏î‡πâ‡∏ß‡∏¢ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ aphthous or linear ulcers ‡∏≠‡∏µ‡∏Å UC ‡∏à‡∏∞‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô (and common) ‡∏ß‡πà‡∏≤‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà rectum ‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡πÅ‡∏ö‡∏ö continuous   Epidemiology  ‡∏û‡∏ö‡πÄ‡∏¢‡∏≠‡πÉ‡∏ô‡∏ï‡∏∞‡∏ß‡∏±‡∏ô‡∏ï‡∏Å UC ‡∏û‡∏ö‡πÑ‡∏î‡πâ‡∏ö‡πà‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤ CD ‡πÅ‡∏ï‡πà‡∏ï‡πà‡∏≤‡∏á‡∏Å‡∏±‡∏ô‡∏ô‡∏¥‡∏î‡πÄ‡∏î‡∏µ‡∏¢‡∏ß   Pathophysiology (‡∏´‡∏•‡∏≤‡∏Å‡∏´‡∏•‡∏≤‡∏¢, in short;)  microbiome ‡πÄ‡∏™‡∏µ‡∏¢‡∏™‡∏°‡∏î‡∏∏‡∏• ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∞‡∏ó‡∏≤‡∏ô‡∏≠‡∏≤‡∏´‡∏≤‡∏£ FODMAPs Psychological Stress TNF-a ‡∏ó‡∏µ‡πà‡∏™‡∏π‡∏á ‡∏ó‡∏≥‡πÉ‡∏´‡πâ th1 th2 dysfunction   Severity  Mild  ‡∏ñ‡πà‡∏≤‡∏¢‡∏ô‡πâ‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ESR ‡∏õ‡∏Å‡∏ï‡∏¥ (< 30 mm/h)   Moderate  ‡∏ñ‡πà‡∏≤‡∏¢‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á systemic ‡πÄ‡∏•‡πá‡∏Å‡∏ô‡πâ‡∏≠‡∏¢   Severe  ‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 6 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ‡∏°‡∏µ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏¥‡∏á‡∏£‡∏∞‡∏ö‡∏ö   Fulminant  ‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 10 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ‡∏Å‡∏î‡πÄ‡∏à‡πá‡∏ö S&S of toxic megacolon     Extraintestinal manifestations ‡πÄ‡∏î‡πà‡∏ô‡πÉ‡∏ô CD ‡πÄ‡∏ä‡πà‡∏ô Uveitis, Scleritis, Episcleritis ‡∏õ‡∏ß‡∏î‡∏Ç‡πâ‡∏≠ ‡∏õ‡∏ß‡∏î‡πÄ‡∏Ç‡πà‡∏≤‡∏Å‡πá‡∏û‡∏ö‡πÑ‡∏î‡πâ‡πÄ‡∏ä‡πà‡∏ô‡∏Å‡∏±‡∏ô Goal of Therapy:  ‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏∏‡∏ô‡πÅ‡∏£‡∏á ‡∏õ‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏Å‡∏¥‡∏î‡∏†‡∏≤‡∏ß‡∏∞‡∏∞‡πÅ‡∏ó‡∏£‡∏Å‡∏ã‡πâ‡∏≠‡∏ô ‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ñ‡∏µ‡πà‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏Å‡∏≥‡πÄ‡∏£‡∏¥‡∏ö   ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤‡πÇ‡∏î‡∏¢‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏¢‡∏≤  Salicylate derivatives ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á induction and maintenance  ‡∏ï‡∏±‡∏ß active ‡∏Ñ‡∏∑‡∏≠ 5-aminosalicylic acid (mesalamine) ‡∏°‡∏µ‡∏ú‡∏•‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏Ñ‡∏µ‡∏¢‡∏á‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡πÑ‡∏î‡πâ‡πÅ‡∏Å‡πà ‡∏Ñ‡∏•‡∏∑‡πà‡∏ô‡πÑ‡∏™‡πâ ‡∏≠‡∏≤‡πÄ‡∏à‡∏µ‡∏¢‡∏ô ‡∏õ‡∏ß‡∏î‡∏®‡∏£‡∏µ‡∏©‡∏∞ ‡πÄ‡∏ö‡∏∑‡πà‡∏≠‡∏≠‡∏≤‡∏´‡∏≤‡∏£ Sulfasalazine (sulfapyridine + 5-ASA)  ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡∏ú‡∏°‡∏£‡πà‡∏ß‡∏á ‡∏ú‡∏∑‡πà‡∏ô‡πÅ‡∏û‡πâ ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á ‡∏™‡∏≤‡∏£‡∏Ñ‡∏±‡∏î‡∏´‡∏•‡∏±‡πà‡∏á‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡∏™‡∏µ‡∏™‡πâ‡∏° (‡∏ô‡πâ‡∏≥‡∏ï‡∏≤ ‡πÄ‡∏´‡∏á‡∏∑‡πà‡∏≠ ‡∏õ‡∏±‡∏™‡∏™‡∏≤‡∏ß‡∏∞) ‡∏£‡∏∞‡∏ß‡∏±‡∏á anemia thrombocytopenia ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡πÉ‡∏ô‡∏Ñ‡∏ô‡πÅ‡∏û‡πâ sulfa sulfapyridine ‡πÄ‡∏õ‡πá‡∏ô antibiotics ‡πÅ‡∏ï‡πà‡πÄ‡∏£‡∏≤‡∏ô‡∏≥‡∏°‡∏≤‡∏ú‡∏™‡∏°‡πÄ‡∏û‡∏∑‡πà‡∏≠‡πÉ‡∏ä‡πâ‡πÄ‡∏õ‡πá‡∏ô carriers ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ ‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏ï‡∏±‡∏ß 5-ASA ‡∏î‡∏π‡∏î‡∏ã‡∏∂‡∏°‡πÑ‡∏î‡πâ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ô‡πâ‡∏≠‡∏¢   ‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡πÄ‡∏£‡∏≤‡∏°‡∏µ mesalamine ‡πÄ‡∏î‡∏µ‡πà‡∏¢‡∏ß ‡∏ó‡∏±‡πâ‡∏á‡πÉ‡∏ô‡∏£‡∏π‡∏õ‡∏Ç‡∏≠‡∏á suppository, enema, oral   Corticosteroids ‡∏°‡∏±‡∏Å‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö‡∏¢‡∏≤‡∏ï‡∏±‡∏ß‡∏≠‡∏∑‡πà‡∏ô‡∏î‡πâ‡∏ß‡∏¢‡πÄ‡∏™‡∏°‡∏≠  Prednisolone ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡πÅ‡∏Ñ‡πà‡πÉ‡∏ô severe ‡∏õ‡∏Å‡∏ï‡∏¥‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 40-60 mg/d ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 2-3 ‡∏ß‡∏µ‡∏Ñ Budesonide ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á mild-mod-severe   Thiopurine (Azathioprine; pro-drug)  ‡∏ï‡πâ‡∏≠‡∏á‡∏ó‡∏î‡∏™‡∏≠‡∏ö TPMT   Anti-TNF  ‡∏´‡πâ‡∏≤‡∏°‡πÉ‡∏ä‡πâ‡πÉ‡∏ô toxic megacolon ‡πÅ‡∏•‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏ä‡πá‡∏Ñ lab TPS, hepatitis   Anti-integrin, IL-12, IL-23 inhibitor, JAK inhibitor, Calcineurin inhibitor ‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡πÄ‡∏Ñ‡∏™‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡∏ï‡∏≠‡∏ö‡∏™‡∏ô‡∏≠‡∏á‡∏ï‡πà‡∏≠ steroid ‡πÅ‡∏•‡∏∞‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡πÅ‡∏Ñ‡πà induction ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ S/E ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏¢‡∏≠‡∏∞‡∏°‡∏≤‡∏Å ‡πÜ   ‡πÅ‡∏ô‡∏ß‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤  ‡∏à‡∏∏‡∏î‡∏™‡∏±‡∏á‡πÄ‡∏Å‡∏ï: ‡πÉ‡∏ô fulminant ‡∏à‡∏∞‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏û‡∏ß‡∏Å methyprednisolone / hydrocortisone ‡∏Å‡πà‡∏≠‡∏ô ‡∏ñ‡πâ‡∏≤‡∏´‡∏≤‡∏¢‡∏Ñ‡πà‡∏≠‡∏¢‡∏•‡∏î‡πÄ‡∏õ‡πá‡∏ô prednisolone ‡πÉ‡∏ô Cohn Disease ‡∏ñ‡πâ‡∏≤ Severe or Mod ‡∏≠‡∏≤‡∏à‡πÉ‡∏ä‡πâ Prednisolone ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö TNF-a inhibitor ‡∏´‡∏£‡∏∑‡∏≠ immunosupressive ‡πÑ‡∏õ‡πÄ‡∏•‡∏¢ !"><meta name=twitter:image content="https://akumaharit.github.io/quartz/icon.png"><title>ü™¥ Harit's External Brain</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel="shortcut icon" type=image/png href=https://akumaharit.github.io/quartz//icon.png><link href=https://akumaharit.github.io/quartz/styles.b369a84b3c6e6bfd686ad1f9da65641c.min.css rel=stylesheet><link href=https://akumaharit.github.io/quartz/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://akumaharit.github.io/quartz/js/darkmode.a68a7442418d0a27fed8a6af6c0a0229.min.js></script>
<script src=https://akumaharit.github.io/quartz/js/util.a0ccf91e1937fe761a74da4946452710.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/npm/@floating-ui/core@1.2.1></script>
<script src=https://cdn.jsdelivr.net/npm/@floating-ui/dom@1.2.1></script>
<script async src=https://akumaharit.github.io/quartz/js/popover.aa9bc99c7c38d3ae9538f218f1416adb.min.js></script>
<script defer src=https://akumaharit.github.io/quartz/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://akumaharit.github.io/quartz/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://akumaharit.github.io/quartz/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://akumaharit.github.io/quartz/",fetchData=Promise.all([fetch("https://akumaharit.github.io/quartz/indices/linkIndex.bff4888056c9000936caf90dcafa7696.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://akumaharit.github.io/quartz/indices/contentIndex.510277b3b3dcf470cf9fecbe31152d7e.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://akumaharit.github.io/quartz",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://akumaharit.github.io/quartz",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}var i=document.getElementsByClassName("mermaid");i.length>0&&import("https://unpkg.com/mermaid@9/dist/mermaid.esm.min.mjs").then(e=>{e.default.init()});function a(n){const e=n.target,t=e.className.split(" "),s=t.includes("broken"),o=t.includes("internal-link");plausible("Link Click",{props:{href:e.href,broken:s,internal:o,graph:!1}})}const r=document.querySelectorAll("a");for(link of r)link.className.includes("root-title")&&link.addEventListener("click",a,{once:!0})},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'‚Äô':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/akumaharit.github.io\/quartz\/js\/router.d6fe6bd821db9ea97f9aeefae814d8e7.min.js"
    attachSPARouting(init, render)
  </script><script defer data-domain=akumaharit.github.io/quartz src=https://plausible.io/js/script.js></script>
<script>window.plausible=window.plausible||function(){(window.plausible.q=window.plausible.q||[]).push(arguments)}</script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=Search placeholder="Search for something..."><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://akumaharit.github.io/quartz/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a class=root-title href=https://akumaharit.github.io/quartz/>ü™¥ Harit's External Brain</a></h1><div class=spacer></div><div id=search-icon><p>Search</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">Search Icon</title><desc id="desc">Icon to open search</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>Light Mode</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>Dark Mode</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><p class=meta>Last updated
Mar 8, 2023</p><ul class=tags></ul><blockquote class=warning-callout><p>IBD ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà IBS
IBS ‡πÄ‡∏õ‡πá‡∏ô functional ‡∏ï‡πà‡∏≤‡∏á‡∏ó‡∏µ‡πà IBD ‡∏ó‡∏µ‡πà‡∏û‡∏¢‡∏≤‡∏ò‡∏¥‡∏™‡∏†‡∏≤‡∏û‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô</p></blockquote><ul><li><strong>Crohn&rsquo;s Disease vs Ulcerative Colitis</strong><ul><li>UC ‡∏à‡∏≥‡∏ß‡πà‡∏≤ &ldquo;‡πÄ‡∏≠‡∏≤‡∏™‡∏¥&rdquo; = S&S ‡πÄ‡∏î‡πà‡∏ô‡∏ï‡∏£‡∏á rectum ‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏¢ ‡πÜ ‡πÅ‡∏ï‡πà‡πÑ‡∏°‡πà‡∏•‡∏∂‡∏Å‡∏°‡∏≤‡∏Å ‡∏ï‡πà‡∏≤‡∏á‡∏à‡∏≤‡∏Å CD ‡∏ó‡∏µ‡πà‡∏Å‡∏£‡∏∞‡∏à‡∏±‡∏î‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢</li><li>‡πÄ‡∏û‡∏£‡∏≤‡∏∞ CD ‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô systemic symptoms ‡∏à‡∏∂‡∏á‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏°‡∏≤‡∏Å ‡πÜ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á abdominal ‡∏ó‡∏µ‡πà‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏≠‡∏µ‡∏Å ‡πÄ‡∏ä‡πà‡∏ô tenderness, pain ‡∏Ø‡∏•‡∏Ø ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á‡πÑ‡∏Ç‡πâ‡∏≠‡∏µ‡∏Å‡∏î‡πâ‡∏ß‡∏¢ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ aphthous or linear ulcers ‡∏≠‡∏µ‡∏Å</li><li>UC ‡∏à‡∏∞‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô (and common) ‡∏ß‡πà‡∏≤‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà rectum ‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡πÅ‡∏ö‡∏ö continuous</li></ul></li><li>Epidemiology<ul><li>‡∏û‡∏ö‡πÄ‡∏¢‡∏≠‡πÉ‡∏ô‡∏ï‡∏∞‡∏ß‡∏±‡∏ô‡∏ï‡∏Å</li><li>UC ‡∏û‡∏ö‡πÑ‡∏î‡πâ‡∏ö‡πà‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤ CD ‡πÅ‡∏ï‡πà‡∏ï‡πà‡∏≤‡∏á‡∏Å‡∏±‡∏ô‡∏ô‡∏¥‡∏î‡πÄ‡∏î‡∏µ‡∏¢‡∏ß</li></ul></li><li>Pathophysiology (‡∏´‡∏•‡∏≤‡∏Å‡∏´‡∏•‡∏≤‡∏¢, in short;)<ul><li>microbiome ‡πÄ‡∏™‡∏µ‡∏¢‡∏™‡∏°‡∏î‡∏∏‡∏•</li><li>‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∞‡∏ó‡∏≤‡∏ô‡∏≠‡∏≤‡∏´‡∏≤‡∏£ FODMAPs</li><li>Psychological Stress</li><li>TNF-a ‡∏ó‡∏µ‡πà‡∏™‡∏π‡∏á ‡∏ó‡∏≥‡πÉ‡∏´‡πâ th1 th2 dysfunction</li></ul></li><li>Severity<ul><li>Mild<ul><li>‡∏ñ‡πà‡∏≤‡∏¢‡∏ô‡πâ‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á</li><li>ESR ‡∏õ‡∏Å‡∏ï‡∏¥ (&lt; 30 mm/h)</li></ul></li><li>Moderate<ul><li>‡∏ñ‡πà‡∏≤‡∏¢‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á</li><li>systemic ‡πÄ‡∏•‡πá‡∏Å‡∏ô‡πâ‡∏≠‡∏¢</li></ul></li><li>Severe<ul><li>‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 6 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á</li><li>‡∏°‡∏µ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏¥‡∏á‡∏£‡∏∞‡∏ö‡∏ö</li></ul></li><li>Fulminant<ul><li>‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 10 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á</li><li>‡∏Å‡∏î‡πÄ‡∏à‡πá‡∏ö</li><li>S&S of toxic megacolon</li></ul></li></ul></li><li>Extraintestinal manifestations ‡πÄ‡∏î‡πà‡∏ô‡πÉ‡∏ô CD ‡πÄ‡∏ä‡πà‡∏ô Uveitis, Scleritis, Episcleritis ‡∏õ‡∏ß‡∏î‡∏Ç‡πâ‡∏≠ ‡∏õ‡∏ß‡∏î‡πÄ‡∏Ç‡πà‡∏≤‡∏Å‡πá‡∏û‡∏ö‡πÑ‡∏î‡πâ‡πÄ‡∏ä‡πà‡∏ô‡∏Å‡∏±‡∏ô</li><li>Goal of Therapy:<ul><li>‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏∏‡∏ô‡πÅ‡∏£‡∏á</li><li>‡∏õ‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏Å‡∏¥‡∏î‡∏†‡∏≤‡∏ß‡∏∞‡∏∞‡πÅ‡∏ó‡∏£‡∏Å‡∏ã‡πâ‡∏≠‡∏ô</li><li>‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ñ‡∏µ‡πà‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏Å‡∏≥‡πÄ‡∏£‡∏¥‡∏ö</li></ul></li><li>‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤‡πÇ‡∏î‡∏¢‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏¢‡∏≤<ul><li><strong>Salicylate derivatives</strong> ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á induction and maintenance<ul><li>‡∏ï‡∏±‡∏ß active ‡∏Ñ‡∏∑‡∏≠ 5-aminosalicylic acid (mesalamine) ‡∏°‡∏µ‡∏ú‡∏•‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏Ñ‡∏µ‡∏¢‡∏á‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡πÑ‡∏î‡πâ‡πÅ‡∏Å‡πà ‡∏Ñ‡∏•‡∏∑‡πà‡∏ô‡πÑ‡∏™‡πâ ‡∏≠‡∏≤‡πÄ‡∏à‡∏µ‡∏¢‡∏ô ‡∏õ‡∏ß‡∏î‡∏®‡∏£‡∏µ‡∏©‡∏∞ ‡πÄ‡∏ö‡∏∑‡πà‡∏≠‡∏≠‡∏≤‡∏´‡∏≤‡∏£</li><li>Sulfasalazine (sulfapyridine + 5-ASA)<ul><li>‡∏£‡∏∞‡∏ß‡∏±‡∏á‡∏ú‡∏°‡∏£‡πà‡∏ß‡∏á ‡∏ú‡∏∑‡πà‡∏ô‡πÅ‡∏û‡πâ ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á ‡∏™‡∏≤‡∏£‡∏Ñ‡∏±‡∏î‡∏´‡∏•‡∏±‡πà‡∏á‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡∏™‡∏µ‡∏™‡πâ‡∏° (‡∏ô‡πâ‡∏≥‡∏ï‡∏≤ ‡πÄ‡∏´‡∏á‡∏∑‡πà‡∏≠ ‡∏õ‡∏±‡∏™‡∏™‡∏≤‡∏ß‡∏∞)</li><li>‡∏£‡∏∞‡∏ß‡∏±‡∏á anemia thrombocytopenia</li><li>‡∏£‡∏∞‡∏ß‡∏±‡∏á‡πÉ‡∏ô‡∏Ñ‡∏ô‡πÅ‡∏û‡πâ sulfa</li><li>sulfapyridine ‡πÄ‡∏õ‡πá‡∏ô antibiotics ‡πÅ‡∏ï‡πà‡πÄ‡∏£‡∏≤‡∏ô‡∏≥‡∏°‡∏≤‡∏ú‡∏™‡∏°‡πÄ‡∏û‡∏∑‡πà‡∏≠‡πÉ‡∏ä‡πâ‡πÄ‡∏õ‡πá‡∏ô carriers ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ ‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏ï‡∏±‡∏ß 5-ASA ‡∏î‡∏π‡∏î‡∏ã‡∏∂‡∏°‡πÑ‡∏î‡πâ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ô‡πâ‡∏≠‡∏¢</li></ul></li><li>‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡πÄ‡∏£‡∏≤‡∏°‡∏µ mesalamine ‡πÄ‡∏î‡∏µ‡πà‡∏¢‡∏ß ‡∏ó‡∏±‡πâ‡∏á‡πÉ‡∏ô‡∏£‡∏π‡∏õ‡∏Ç‡∏≠‡∏á suppository, enema, oral</li></ul></li><li>Corticosteroids ‡∏°‡∏±‡∏Å‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö‡∏¢‡∏≤‡∏ï‡∏±‡∏ß‡∏≠‡∏∑‡πà‡∏ô‡∏î‡πâ‡∏ß‡∏¢‡πÄ‡∏™‡∏°‡∏≠<ul><li>Prednisolone ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡πÅ‡∏Ñ‡πà‡πÉ‡∏ô severe ‡∏õ‡∏Å‡∏ï‡∏¥‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 40-60 mg/d ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 2-3 ‡∏ß‡∏µ‡∏Ñ</li><li>Budesonide ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á mild-mod-severe</li></ul></li><li>Thiopurine (Azathioprine; pro-drug)<ul><li>‡∏ï‡πâ‡∏≠‡∏á‡∏ó‡∏î‡∏™‡∏≠‡∏ö TPMT</li></ul></li><li>Anti-TNF<ul><li>‡∏´‡πâ‡∏≤‡∏°‡πÉ‡∏ä‡πâ‡πÉ‡∏ô toxic megacolon ‡πÅ‡∏•‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏ä‡πá‡∏Ñ lab TPS, hepatitis</li></ul></li><li>Anti-integrin, IL-12, IL-23 inhibitor, JAK inhibitor, Calcineurin inhibitor ‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡πÄ‡∏Ñ‡∏™‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡∏ï‡∏≠‡∏ö‡∏™‡∏ô‡∏≠‡∏á‡∏ï‡πà‡∏≠ steroid ‡πÅ‡∏•‡∏∞‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡πÅ‡∏Ñ‡πà induction ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ S/E ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏¢‡∏≠‡∏∞‡∏°‡∏≤‡∏Å ‡πÜ</li></ul></li><li>‡πÅ‡∏ô‡∏ß‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤<ul><li>‡∏à‡∏∏‡∏î‡∏™‡∏±‡∏á‡πÄ‡∏Å‡∏ï: ‡πÉ‡∏ô fulminant ‡∏à‡∏∞‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏û‡∏ß‡∏Å methyprednisolone / hydrocortisone ‡∏Å‡πà‡∏≠‡∏ô ‡∏ñ‡πâ‡∏≤‡∏´‡∏≤‡∏¢‡∏Ñ‡πà‡∏≠‡∏¢‡∏•‡∏î‡πÄ‡∏õ‡πá‡∏ô prednisolone</li><li>‡πÉ‡∏ô Cohn Disease ‡∏ñ‡πâ‡∏≤ Severe or Mod ‡∏≠‡∏≤‡∏à‡πÉ‡∏ä‡πâ Prednisolone ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö TNF-a inhibitor ‡∏´‡∏£‡∏∑‡∏≠ immunosupressive ‡πÑ‡∏õ‡πÄ‡∏•‡∏¢</li><li><a class="internal-link broken">Pasted image 20230305193915.png</a></li><li><a class="internal-link broken">Pasted image 20230305193929.png</a></li></ul></li><li>‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡πÇ‡∏†‡∏ä‡∏ô‡∏≤‡∏Å‡∏≤‡∏£‡πÉ‡∏ô‡∏Ñ‡∏ô‡πÑ‡∏Ç‡πâ IBD<ul><li>‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏Ñ‡∏ô‡πÑ‡∏Ç‡πâ‡∏°‡∏µ IL-6 ‡πÅ‡∏•‡∏∞ TNF-a ‡∏ó‡∏µ‡πà‡∏™‡∏π‡∏á‡∏´‡∏£‡∏∑‡∏≠‡πÄ‡∏¢‡∏≠‡∏∞‡∏ú‡∏¥‡∏î‡∏õ‡∏Å‡∏ï‡∏¥ ‡∏à‡∏∂‡∏á‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏π‡∏ç‡πÄ‡∏™‡∏µ‡∏¢‡πÇ‡∏õ‡∏£‡∏ï‡∏µ‡∏ô ‡πÅ‡∏•‡∏∞ muscle wasting ‡πÑ‡∏î‡πâ</li><li>‡∏Ñ‡∏ô‡πÑ‡∏Ç‡πâ‡∏Å‡∏¥‡∏ô‡πÑ‡∏£‡πÑ‡∏°‡πà‡∏Ñ‡πà‡∏≠‡∏¢‡πÑ‡∏î‡πâ ‡∏à‡∏∂‡∏á‡∏õ‡∏ß‡∏î‡∏ó‡πâ‡∏≠‡∏á ‡∏≠‡∏µ‡∏Å‡∏ó‡∏±‡πâ‡∏á‡∏î‡∏π‡∏î‡∏ã‡∏∂‡∏°‡∏™‡∏≤‡∏£‡∏≠‡∏≤‡∏´‡∏≤‡∏£‡πÑ‡∏î‡πâ‡∏ô‡πâ‡∏≠‡∏¢‡∏≠‡∏µ‡∏Å‡∏î‡πâ‡∏ß‡∏¢ ‡∏°‡∏µ‡πÄ‡∏ö‡∏∑‡πà‡∏≠‡∏≠‡∏≤‡∏´‡∏≤‡∏£‡∏£‡πà‡∏ß‡∏°‡∏î‡πâ‡∏ß‡∏¢</li></ul></li><li>‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤‡πÇ‡∏î‡∏¢‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πâ‡∏¢‡∏≤<ul><li>‡∏Å‡∏≤‡∏£‡∏ú‡πà‡∏≤‡∏ï‡∏±‡∏î ‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡∏Ñ‡∏ô‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡∏ï‡∏≠‡∏ö‡∏™‡∏ô‡∏≠‡∏á</li><li>‡∏Å‡∏≤‡∏£‡∏î‡∏π‡πÅ‡∏•‡∏î‡πâ‡∏≤‡∏ô‡πÇ‡∏†‡∏ä‡∏ô‡∏≤‡∏Å‡∏≤‡∏£, FODMAP / probiotics ‡∏ï‡πà‡∏≤‡∏á ‡πÜ<ul><li>FODMAPs = Fermentable oligo,di and monosacharides and polyols</li></ul></li><li>‡∏™‡∏£‡πâ‡∏≤‡∏á‡πÄ‡∏™‡∏£‡∏¥‡∏°‡∏™‡∏°‡∏î‡∏∏‡∏• gut microbiota ‡πÅ‡∏•‡∏∞‡πÄ‡∏û‡∏¥‡πà‡∏° short chain fatty acid ‡πÇ‡∏î‡∏¢ probiotics ‡πÅ‡∏•‡∏∞ soluble fiber</li><li>‡πÅ‡∏û‡∏ó‡∏¢‡πå‡∏ó‡∏≤‡∏á‡πÄ‡∏•‡∏∑‡∏≠‡∏Å ‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡πÉ‡∏´‡πâ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏π‡πâ</li><li>‡πÄ‡∏•‡∏µ‡πà‡∏¢‡∏á‡∏≠‡∏≤‡∏´‡∏≤‡∏£‡∏ó‡∏µ‡πà‡∏£‡∏∞‡∏ö‡∏∏‡πÑ‡∏î‡πâ‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô‡πÅ‡∏•‡πâ‡∏ß‡∏ß‡πà‡∏≤‡∏Å‡∏£‡∏∞‡∏ï‡∏∏‡πâ‡∏ô‡∏ï‡∏±‡∏ß‡πÇ‡∏£‡∏Ñ ‡πÅ‡∏ï‡πà‡∏Å‡πá‡∏£‡∏∞‡∏ß‡∏±‡∏á malnutrition ‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô‡πÄ‡∏•‡∏µ‡πà‡∏¢‡∏á‡πÅ‡∏Ñ‡πà‡∏ó‡∏µ‡πà‡∏°‡∏±‡πà‡∏ô‡πÉ‡∏à‡πÄ‡∏ó‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô<ul><li>‡πÄ‡∏ä‡πà‡∏ô FODMAPs, sulfur/sulfate, ‡πÄ‡∏Ñ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏î‡∏∑‡πà‡∏° alcohol, ‡∏ô‡∏° (lactose), ‡πÄ‡∏ô‡∏∑‡πâ‡∏≠‡πÅ‡∏î‡∏á</li></ul></li></ul></li></ul></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>Backlinks</h3><ul class=backlinks><li><a href=/quartz// data-ctx=notes/IBD data-src=/ class=internal-link>ü™¥ Harit's External Brain</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>Interactive Graph</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://akumaharit.github.io/quartz/js/graph.6579af7b10c818dbd2ca038702db0224.js></script></div></div><div id=contact_buttons><footer><p>Made by Harit Jeamvijit using <a href=https://github.com/jackyzha0/quartz>Quartz</a>, ¬© 2023</p><ul><li><a href=https://akumaharit.github.io/quartz/>Home</a></li><li><a href=https://github.com/akumaharit/>GitHub</a></li></ul></footer></div></div></body></html>